Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-005919

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 25, 2018
Accepted (ET)
Jan 29, 2018 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jan 25, 2018S5,000$20.31D21,946ISee Footnote
Common StockF4,F5Jan 25, 2018S3,054$20.22D44,351ISee Footnote
Common StockF6,F3Jan 26, 2018S5,000$20.46D16,946ISee Footnote
Common StockF7,F3Jan 29, 2018S5,000$21.36D11,946ISee Footnote
Common Stockholding———286,975D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses